Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...
Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
3d
‘I can't shake the anxiety about weight regain if I'm priced out of Mounjaro’: On life after GLP-1s
One writer felt she'd finally reached her bodily happy ever after via GLP-1 jabs. But with soaring prices and scientific unknowns on the horizon...now what?
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
U .S. pharmaceutical company Eli Lilly (LLY) has announced plans to build a $3 billion manufacturing plant in the Netherlands ...
Eli Lilly announced that its experimental weight-loss pill, orforglipron, meets most of the criteria for the U.S. Food and ...
U.S. pharmaceutical company Eli Lilly (LLY) says that the weight-loss pill it is developing should be a candidate for ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
The idea was beautifully simple. One pill taken daily to melt away those excess pounds. The new breed of GLP-1 oral ...
Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback